Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

New ketamine study promises extended relief for depression

Written by | 4 Jun 2025

Roughly 10 percent of the U.S. population is afflicted with major depressive disorder at any given time, and up to 20 percent will exhibit MDD symptoms over their lifetimes. Yet… read more.

Hallucinogen use linked to 2.6-fold increase in risk of death for people needing emergency care

Written by | 14 Mar 2025

People seeking emergency care for hallucinogen use were at 2.6-fold higher risk of death within 5 years than the general population, according to a new study published in CMAJ (Canadian Medical… read more.

Multisite clinical trial will compare three FDA-approved drugs for Rett syndrome treatment

Written by | 5 Feb 2024

Vanderbilt University Medical Center received a $13 million Department of Defense grant to lead a multisite clinical trial that will evaluate repurposed FDA-approved drugs as treatment options for… read more.

Ketamine nasal spray may prove safe and effective treatment for refractory migraine

Written by | 3 Jun 2023

Ketamine taken in the form of a nasal spray may prove a safe and effective treatment for refractory chronic migraine, suggests a single centre study, published in the… read more.

Study finds ketamine is at least as effective as ECT for treating major depression

Written by | 29 May 2023

A new study led by investigators from Mass General Brigham has found that subanesthetic intravenous ketamine was effective and not inferior to electroconvulsive therapy (ECT) for the treatment of non-psychotic,… read more.

Ketamine found to increase brain noise

Written by | 30 Dec 2022

An international team of researchers including Sofya Kulikova, Senior Research Fellow at the HSE University-Perm, found that ketamine, being an NMDA receptor inhibitor, increases the brain’s background noise, causing higher… read more.

Low addiction risk with medical use of ketamine

Written by | 6 Aug 2022

Commonly used in medicine as an anaesthetic, ketamine is also increasingly prescribed to relieve depressive symptoms. This very fast-acting psychotropic drug is particularly indicated for the treatment of… read more.

Ketamine is effective for severe suicidal ideation

Written by | 16 Feb 2022

Ketamine is effective for the acute treatment of severe suicidal ideation, researchers reported on February 2, 2022 in The BMJ/British Medical Journal. “This study confirmed in a large… read more.

Statistical model defines ketamine anesthesia’s effects on the brain

Written by | 13 Sep 2021

By developing the first statistical model to finely characterize how ketamine anesthesia affects the brain, a team of researchers at MIT’s Picower Institute for Learning and Memory and… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.